×
Back to Agenda
Session 1: Methods and Case Examples of Practical Application
Session Chair(s)
Robert Massouh, MPHARM, RPH
Head of Safety (PV) Risk Management and Benefit/Risk Evaluation, GSK, United Kingdom
Speaker(s)
Jamie Wilkins, PHARMD
Head, Risk Management Center of Excellence, Pfizer Inc, United States
Determining global RMM approach
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV, Abbvie, United Kingdom
Stakeholder engagement in aRMMs – maximising value and minimising tokenism
Mark Perrott, PHD
Managing Partner, Axian Consulting Ltd., United Kingdom
Failure modes effect analysis to proactively reduce disabling factors of RMM effectiveness
Meredith Yearsley Smith, MPA, FISPE
Fellow and faculty member, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
Mixed methods to support formative and evaluative RMM assessment
Have an account?